Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HPV/Genital Warts Health Center

Font Size

Experimental Vaccine Targets Genital Cancer

Study Shows Vaccine Is Effective in Women Who Are Already Infected With HPV
WebMD Health News
Reviewed by Louise Chang, MD

Nov. 4, 2009 -- An experimental human papilloma virus (HPV) vaccine shows early promise for preventing genital cancer in high-risk women who are already infected with the virus.

Infected women with precancerous lesions caused by HPV showed regression of the lesions after being given the experimental vaccine in a study reported today by researchers from the Netherlands in the New England Journal of Medicine.

The study included just 20 women. Researchers tell WebMD they are working to improve the vaccine before moving on to larger trials.

But the findings suggest it may be possible to prevent genital cancers by vaccinating HPV-infected women at high risk for developing the disease. "We were able to successfully treat women with these HPV-caused lesions," study researcher Gemma G. Kenter, MD, PhD, says. "And we were able to show lesion regression over a two-year period."

The two commercially available HPV vaccines, Gardasil and Cervarix, are designed to prevent initial infection with specific strains of the sexually transmitted HPV virus that cause most cervical cancers.

Because of this, they are most effective when given before the onset of sexual activity. The CDC recommends that the vaccine be given to girls between the ages of 11 and 12 and that it not be given to women older than 26.

Like the commercially available vaccines, the experimental vaccine targets the HPV 16 virus, which is a leading cause of cervical cancer and other genital cancers.

Women at High Risk for Cancer

The women in the study all had the precancerous genital lesions, known as vulvar intraepithelial neoplasia (VIN), which put them at high risk for developing cancer of the vulva. The lesions were also advanced enough to require treatment.

The women were vaccinated up to four times with the experimental vaccine.

Three months after treatment, 12 of the 20 women had clinical responses and reported relief of symptoms such as persistent itching. Five of the women had complete regression of their lesions and evidence of HPV-16 infection was no longer detectable in four of them.

Two years after treatment, about half the women no longer had the lesions and had no symptoms.

Today on WebMD

HPV Vaccine Future
STD Overview
STD Facts Quiz
Syringes and graph illustration
Sex Drive Killers
Genital Herpes Risks Quiz
Young couple holding hands
Herpes Vaccine Study
Condom Quiz
HPV Symptoms Tests
Get The STD Picture
cancer cell

WebMD Special Sections